Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Abstract PARP inhibitors have been proposed as a potential targeted therapy for patients with triple‐negative (ER‐, PR‐, HER2‐negative) breast cancers. However, it is as yet unclear as to whether single agent or combination therapy using PARP inhibitors would be most beneficial. To better understand...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Nature
2012-08-01
|
| Reeks: | EMBO Molecular Medicine |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/emmm.201201250 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|